Present study aims to investigate the acute effects of St John’s Wort (SJW) on nicotine withdrawal syndrome and serotonergic hypo activity in mice. Adult male Albino mice weighing 20-25g were housed 6 per cage under light and dark conditions at 22±3oC and maintained on lab chow and water ad libitum under standard housing conditions. Nicotine was administered at the concentrations of 3.08mg (1mg of free base) in 100 ml of drinking water for 4 weeks. Nicotine withdrawal was achieved by substituting nicotine containing water with drinking water. Nicotine withdrawn (NW) mice were evaluated for locomotor activity and abstinence signs at 72 h. Whole brain tryptophan (TRP). 5-hydroxytryptamine (5-HT) and 5-hydroxyindoleacetic acid (5-HIAA) were measured using high performance liquid chromatography connected to fluorescence detector. St John’s Wort (SJW) (500mg/kg) was given intraperitonially 3 h prior to completion of 72 h of nicotine withdrawal period. Behavioral analysis in SJW administered NW mice showed attenuation in nicotine abstinence signs (shaking, scratching, chewing and facial tremors) and locomotor activity when compared with respective controls. NW mice showed decrease in plasma TRP, brain TRP and 5-HT concentrations while increase in 5-HT turnover and corticosterone concentrations as compared to respective controls. SJW administrated NW mice showed decrease in corticosterone levels and 5-HT turnover while plasma TRP, brain TRP and 5-HT synthesis were increased when compared with similarly treated saline injected group. Our findings warrant SJW’s therapeutic efficacy to alleviate nicotine withdrawal associated depression by virtue of its ability to improve serotonergic activity by increasing brain TRP, 5-HT concentrations and decreased turnover.
Kasper S, Gastpar M, Muller WE, et al. Efficacy of St John’s Wort extract WS 5570 in acute treatment of mild depression: a reanalysis of data from controlled clinical trials. Eur Arch Psychiatry Clin Neurosci 2008; 258: 59-63. http://dx.doi.org/10.1007/s00406-007-0779-2
Klemow KM, Bartlow A, Crawford J, Kocher N, Shah J, Ritsick M. Medical Attributes of St. John’s Wort (Hypericum perforatum). Editors In: Benzie IFF, Wachtel-Galor S, editors. Source Herbal Medicine: Biomolecular and Clinical Aspects. Chapter 11, 2ndedition. CRC Press, Boca Raton (FL) 2011.
Malin DH, Lake JR, Newlin-Maultsby P, Roberts LK, Lanier JG, Carter VA, Cunningham JS, Wilson OB. Rodent model of nicotine abstinence syndrome. Pharmacol Biochem Behav 1992; 43: 779-784. http://dx.doi.org/10.1016/0091-3057(92)90408-8
Ribeiro EB, Bettiker RL, Bogdanov M, Wurtman RJ. Effects of systemic nicotine on serotonin release in rat brain. Brain Research 1993; 621(2): 311-318. http://dx.doi.org/10.1016/0006-8993(93)90121-3
Yasuda K, Suemaru K, Araki H, Gomita Y. Effect of nicotine cessation on the central serotonergic systems in mice: involvement of 5-HT2 receptors. Naunyn-Schmiedeberg’s Arch Pharmacol 2002; 366: 276-281. http://dx.doi.org/10.1007/s00210-002-0592-4
Mannucci C, Tedesco M, Bellomo M, Caputi AP, Calapai G. Long-term effects of nicotine on the forced swimming test in mice: An experimental model for the study of depression caused by smoke. Neurochemistry International 2006; 49(5): 481-486. http://dx.doi.org/10.1016/j.neuint.2006.03.010
Costall B, Jones BJ, Kelly ME, Naylor RJ, Onaivi ES, Tyers MB. Sites of action of ondansetron to inhibit withdrawal from drugs of abuse. Pharmacol Biochem Behav 1990; 36: 97-104. http://dx.doi.org/10.1016/0091-3057(90)90132-2
Harrison-Woolrych M, Ashton J. Psychiatric adverse events associated with varenicline: an intensive post marketing prospective cohort study in New Zealand. Drug Safety 2011; 34 (9): 763-7. http://dx.doi.org/10.2165/11594450-000000000-00000
Haustein KO, Haffner S, Woodcock BG. A review of the pharmacological and psychopharmacological aspects of smoking and smoking cessation in psychiatric patients. International Journal of Clinical Pharmacology and Therapeutics 2002; 40: 404-418. http://dx.doi.org/10.5414/CPP40404
Berlin I, Anthenelli RM. Monoamine oxidases and tobacco smoking. Int J Neuropsychopharmacol 2001; 4: 33-42. http://dx.doi.org/10.1017/S1461145701002188
Malone KM, Waternaux C, Haas GL, et al. Cigarette smoking, suicidal behavior, and serotonin function in major psychiatric disorders. American Journal Psychiatry 2003; 160: 773-779. http://dx.doi.org/10.1176/appi.ajp.160.4.773
Uzbay IT, Coskun I, OzturkN, Ozturk Y. Effects of St. John’s Wort on ethanol withdrawal syndromes in rats. World J Biol Psychiat 2005; 6 (Suppl. 1): 311.
KumarV, Singh PN, Bhattacharya SK. Anti-stress activity of Indian Hypericumperforatum L. Indian Journal of Experimental Biology 2001; 39: 344-349.
Saddiqe Z, Naeem I, Maimoona A. A review of the antibacterial activity of Hypericum perforatum L. Journal of Ethnopharmacology 2010; 131(3): 511-521. http://dx.doi.org/10.1016/j.jep.2010.07.034
Bano S, Dawood S. Serotonergic mediation effects of St John’s Wort in rats subjected to swim stress. Pak J Pharm Sci 2008; 21(1): 63-69.
Ara I, Bano S. St. John’s Wort modulates brain regional serotonin metabolism in stressed rats. Pak J Pharm Sci 2009; 22(1): 94-101.
Holland HC, Weldon EA. Note on a new technique of recording ambulation in the open field test and its validation. Acta Psychol (Amst) 1968; 28(3): 293-300. http://dx.doi.org/10.1016/0001-6918(68)90020-6
Bloxam DL, Warren WH. Error in the determination of tryptophan in the method of Denckla and Dewey. A revised procedure. Anal Biochem 1974; 60: 621-625. http://dx.doi.org/10.1016/0003-2697(74)90275-9
Glick D, Voredlich D, Levine S. Flourimetric determination of corticosterone and cortisol in 0. 02 and 0. 05ml of plasm aorsubmiligrams of adrenal tissue. Endocrinology 1964; 74: 653-655. http://dx.doi.org/10.1210/endo-74-4-653
Anderson GM, Gerald YJ, Batter DK. Determination of indoles and catechols in rat brain and pineal using liquid chromatography with flourimetric and amphoteric detection. Journal of chromatography 1981; 223: 815-820. http://dx.doi.org/10.1016/S0378-4347(00)80103-6
Butterweck V, Wall A, Lieflander-Wulf U, Winterhoff H, Nahrstedt A. Effects of total extract and fractions of Hypericumperforatum in animals assays for antidepressant activity. Pharmacopsychiatry 1997; 30(suppl): 117-124. http://dx.doi.org/10.1055/s-2007-979531
Phillipp M, Kohnen R, Hiller K. Hypericum extract versus imipramine or placebo in patients with moderate depression: randomized multicentre study of treatment for eight weeks. BMJ 1999; 319: 1534-1539. http://dx.doi.org/10.1136/bmj.319.7224.1534
Catania MA, Firenzuoli F, Crupi A, Mannucci C, Caputi AP, Calapai G. Hypericum perforatum attenuates nicotine withdrawal signs in mice. Psychopharmacology 2003; 169: 186-189. http://dx.doi.org/10.1007/s00213-003-1492-0
Kasper S, Caraci F, Forti B, Drago F, Aguglia E. Efficacy and tolerability of Hypericum extract for the treatment of mild to moderate depression. European Neuropsychopharmacology 2010; 20: 747-765. http://dx.doi.org/10.1016/j.euroneuro.2010.07.005
Bukhari IA, Dar A. Behavioral profile of Hypericum perforatum (St. John's Wort) extract. A comparison with standard anti-depressants in animal models of depression. Eur Rev Med Pharmacol Sci 2013; 17 (8): 1082-1089.
Uzbay IT, KeyirH, CelikT, Yuksel N. Acute and chronic tianeptine treatment attenuated ethanol withdrawal syndrome in rats. Prog Neuropsychopharmacol Biol Psychiat 2006; 30: 478-485. http://dx.doi.org/10.1016/j.pnpbp.2005.11.013
Calapai G, Crupi A, Firenzuoli F, et al. Effects of Hypericum perforatum on levels of 5-hydroxytryptamine, noradrenaline and dopamine in the cortex, diencephalons and brainstem of the rat. J Pharmacol 1999; 51: 723-728. http://dx.doi.org/10.1211/0022357991772862
Quattrocki E, Baird A, Yurgelun-Tood D. Biological aspects of the link between smoking and depression. Harvard Rev Psychiat 2000; 8: 99-110. http://dx.doi.org/10.1080/hrp_8.3.99
Ohmura Y, Jutkiewicz EM, Yoshioka M, Domino EF. 5-Hydroxytryptophan attenuates somatic signs of nicotine withdrawal. J Pharmacol Sci 2011; 117(2): 121-4. http://dx.doi.org/10.1254/jphs.11074SC
Oldman, AD, Walsh AES, Salkovskis P, et al. Effect of acute tryptophan depletion on mood and appetite in healthy female volunteers. Journal of Psychopharmacology 1994; 8: 8 -13. http://dx.doi.org/10.1177/026988119400800102
Bano S, Gitay M, Ara I, Badawy AA. Acute effects of serotonergic antidepressants on tryptophan metabolism and corticosterone levels in rats. Pak J Pharm Sci 2010; 23 (3): 266-272.
Bano S, Ara I, Saboohi K, Moattar T, Chaoudhry B. St. John’s Wort increases brain serotonin synthesis by inhibiting hepatic tryptophan 2, 3 dioxygenase activity and its gene expression in stressed rats. Pak J Pharm Sci 2014; 27(5): 1427-1435.
Badawy AA, Evans M. Inhibition of rat liver tryptophan pyrrolase activity and elevation of brain tryptophan concentration by administration of antidepressants. Biochem Pharmacol 1981; 30 (11): 1211-1216. http://dx.doi.org/10.1016/0006-2952(81)90299-9
Wurtman RJ, Hefti F, Melamed E. Precursor control of neurotransmitter synthesis Pharmacological Reviews 1981; 32 (4): 315-335.
Badawy AA, Evans M The effects of acute and chronic nicotine hydrogen (+)-tartrate administration and subsequent withdrawal on rat liver tryptophan pyrrolase activity and their comparison with those of morphine, phenobarbitone and ethanol. Biochem J 1975; 148(3): 425-32.
Kokka N, Garcia JF, Elliott HW. Prog Brain Res 1973; 39: 347-360. http://dx.doi.org/10.1016/S0079-6123(08)64091-1
Benwell MEM, Balfour DJK. Effects of chronic nicotine and its withdrawal on plasma corticosterone and brain 5-hydroxyindoles. Psychopharmacology (Berlin) 1979; 63: 7-11. http://dx.doi.org/10.1007/BF00426913
Semba J, Wakuta M, Maeda J, Suhara T. Nicotine withdrawal induces subsensitivity of hypothalamic-pituitary-adrenal axis to stress in rats: implications for precipitation of depression during smoking cessation. Psychoneuroendocrinology 2004; 29: 215-22610. http://dx.doi.org/10.1016/S0306-4530(03)00024-6
Glassman AH, Helzer JE, Covey LS, et al. Smoking, smoking cessation, and major depression. JAMA 1990; 264: 1546-49. http://dx.doi.org/10.1001/jama.1990.03450120058029
Farrell M, Howes S, Babington P, et al. Nicotine, alcohol and drug dependence and psychiatric comorbidity. Results of a national household survey. Br J Psychiatry 2001; 179: 432-37. http://dx.doi.org/10.1192/bjp.179.5.432
Steckler T, Holsboer F, Reul JM. Glucocorticoids and depression. Bailllieres Best Pract Res Clin Endocrinol Metab 1999; 13: 597-617. http://dx.doi.org/10.1053/beem.1999.0046
Fulford AJ, Harbuz MS. An introduction to the HPA axis. In Steckler T, Kalin NH, Reul JMHM (eds), Handbook of stress and the brain. Elsevier BV. Amsterdam. 2005.
Singh VB, Corley KC, Phan H, Boadle-Biber MC. Increases in the activity of tryptophan hydroxylase from rat cortex and midbrain in response to acute or repeated sound stress are blocked by adrenalectomy and restored by dexamethasone treatment. Brain Res 1990; 5(16): 66-76. http://dx.doi.org/10.1016/0006-8993(90)90898-L
Muller WEG, Rolli M, Schafer C, Hafner U. Effects of hypericum extract (LI 160) in biochemical models of antidepressant activity. Pharmapsychiatry 1997; 30: S102-S107. http://dx.doi.org/10.1055/s-2007-979528
Hughes JR, Gust SW, Skoog K, Keenan RM, Fenwick JW. Symptoms of tobacco withdrawal. A replication and extension. Arch Gen Psychiatry 1991; 48: 52-59. http://dx.doi.org/10.1001/archpsyc.1991.01810250054007
Rose JE, Behm FM, Ramsey C, Ritchie JC Jr. Platelet monoamine oxidase, smoking cessation, and tobacco withdrawal symptoms. Nicotine & Tobacco Research 2001; 3(4): 383-90. http://dx.doi.org/10.1080/14622200110087277
Malin DH, Moon WD, Goyarzu P, et al. Inhibition of monoamine oxidase isoforms modulates nicotine withdrawal syndrome in the rat. Life Sci 2013; 93(12-14): 448-53. http://dx.doi.org/10.1016/j.lfs.2013.08.006
Kasper S. Depression and Anxiety-Separate or Continuum. World J Biol Psychiatry 2001; 2: 162-163. http://dx.doi.org/10.3109/15622970109026804
Covey LS, Glassman AH, Stetner F. Depression and depressive symptoms in smoking cessation. Compr Psychiatry 1990; 31: 350-354. http://dx.doi.org/10.1016/0010-440X(90)90042-Q
Breslau N, Kilbey MM, Andreski P. Nicotine withdrawal symptoms and psychiatric disorders: findings from an epidemiologic study of young adults. Am J Psychiatry 1992; 149: 464-469.
Flanagan J, Maany I. Smoking and depression (letter). Am J Psychiatry 1982; 139: 541.
Glassman AH, Covey LS, Dalack GW, et al. Smoking cessation, clonidine, and vulnerability to nicotine among dependent smokers. Clin Pharmacol Ther 1993; 54: 670-679. http://dx.doi.org/10.1038/clpt.1993.205
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2014 Shabana Saeed , Samina Bano